Awarded
Buprenorphin-S (Sublingualtabletten) [Mindestindikation: Substitutionsbehandlung Opiatabhängiger]
- Winners
- ETHYPHARM GmbH, G.L. Pharma Deutschland GmbH (BG GL Pharma Deutschland_GL Pharma), G.L. Pharma GmbH (BG GL Pharma Deutschland_GL Pharma GbR), neuraxpharm Arzneimittel GmbH
- Contract value
- no value published
- Bids received
- 4
- Published
- 19 Sept 2025
- Awarded
- 4 Aug 2025
- Contract start
- 4 Aug 2025